Compare Eiken Chemical Co., Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
JPY 106,042 Million (Small Cap)
25.00
NA
0.00%
-0.07
9.33%
2.42
Revenue and Profits:
Net Sales:
10,947 Million
(Quarterly Results - Dec 2025)
Net Profit:
743 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
23.78%
0%
23.78%
6 Months
31.92%
0%
31.92%
1 Year
38.26%
0%
38.26%
2 Years
52.2%
0%
52.2%
3 Years
94.27%
0%
94.27%
4 Years
87.0%
0%
87.0%
5 Years
37.26%
0%
37.26%
Eiken Chemical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
2.15%
EBIT Growth (5y)
-11.55%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.83
Tax Ratio
25.51%
Dividend Payout Ratio
81.76%
Pledged Shares
0
Institutional Holding
0.35%
ROCE (avg)
17.07%
ROE (avg)
9.70%
Valuation key factors
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
2.30
EV to EBIT
31.11
EV to EBITDA
17.25
EV to Capital Employed
2.40
EV to Sales
2.37
PEG Ratio
0.23
Dividend Yield
NA
ROCE (Latest)
7.70%
ROE (Latest)
9.33%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot : Dec 2016
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.35%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
10,947.00
10,233.00
6.98%
Operating Profit (PBDIT) excl Other Income
1,732.00
1,530.00
13.20%
Interest
5.00
5.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
743.00
2,379.00
-68.77%
Operating Profit Margin (Excl OI)
96.00%
90.70%
0.53%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 6.98% vs 0.35% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -68.77% vs 296.50% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
40,539.00
40,052.00
1.22%
Operating Profit (PBDIT) excl Other Income
5,554.00
5,705.00
-2.65%
Interest
17.00
17.00
Exceptional Items
-250.00
0.00
Consolidate Net Profit
2,228.00
2,634.00
-15.41%
Operating Profit Margin (Excl OI)
74.00%
84.40%
-1.04%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 1.22% vs -7.44% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -15.41% vs -54.08% in Mar 2024
About Eiken Chemical Co., Ltd. 
Eiken Chemical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






